Kyung Dong Pharmaceutical Statistics

Total Valuation

Kyung Dong Pharmaceutical has a market cap or net worth of KRW 167.58 billion. The enterprise value is 178.38 billion.

Market Cap	167.58B
Enterprise Value	178.38B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Kyung Dong Pharmaceutical has 26.94 million shares outstanding. The number of shares has decreased by -0.39% in one year.

Current Share Class	n/a
Shares Outstanding	26.94M
Shares Change (YoY)	-0.39%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	42.54%
Owned by Institutions (%)	1.01%
Float	12.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.89
PB Ratio	0.77
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.49
EV / Sales	0.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.23

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.18.

Current Ratio	1.35
Quick Ratio	0.69
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-2.07
Interest Coverage	-9.92

Financial Efficiency

Return on equity (ROE) is -7.35% and return on invested capital (ROIC) is -3.67%.

Return on Equity (ROE)	-7.35%
Return on Assets (ROA)	-3.31%
Return on Capital (ROIC)	-3.67%
Revenue Per Employee	519.75M
Profits Per Employee	-46.72M
Employee Count	364
Asset Turnover	0.66
Inventory Turnover	2.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.39%
50-Day Moving Average	6,171.00
200-Day Moving Average	6,425.55
Relative Strength Index (RSI)	56.17
Average Volume (20 Days)	45,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kyung Dong Pharmaceutical had revenue of KRW 189.19 billion and -17.00 billion in losses. Loss per share was -629.14.

Revenue	189.19B
Gross Profit	109.02B
Operating Income	-15.28B
Pretax Income	-13.32B
Net Income	-17.00B
EBITDA	-9.87B
EBIT	-15.28B
Loss Per Share	-629.14

Full Income Statement

Balance Sheet

The company has 29.50 billion in cash and 40.04 billion in debt, giving a net cash position of -10.54 billion or -391.08 per share.

Cash & Cash Equivalents	29.50B
Total Debt	40.04B
Net Cash	-10.54B
Net Cash Per Share	-391.08
Equity (Book Value)	218.55B
Book Value Per Share	8,102.00
Working Capital	23.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.13 billion and capital expenditures -7.18 billion, giving a free cash flow of -19.32 billion.

Operating Cash Flow	-12.13B
Capital Expenditures	-7.18B
Free Cash Flow	-19.32B
FCF Per Share	-717.02

Full Cash Flow Statement

Margins

Gross margin is 57.63%, with operating and profit margins of -8.08% and -8.99%.

Gross Margin	57.63%
Operating Margin	-8.08%
Pretax Margin	-7.04%
Profit Margin	-8.99%
EBITDA Margin	-5.22%
EBIT Margin	-8.08%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 400.00, which amounts to a dividend yield of 6.43%.

Dividend Per Share	400.00
Dividend Yield	6.43%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.39%
Shareholder Yield	6.82%
Earnings Yield	-10.11%
FCF Yield	-11.53%

Dividend Details

Stock Splits

The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.

Last Split Date	Apr 20, 2018
Split Type	Forward
Split Ratio	2

Scores

Kyung Dong Pharmaceutical has an Altman Z-Score of 2.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.97
Piotroski F-Score	n/a